Ethical guidelines for our site Australian English Spanish German Hungarian Italian Polish UK English US English


    
in the news

understanding
your tests

inside the lab

about this site

site map

send us your
comments


home
Genetic testing

The future: advances, potential, conclusions

With the completion of the Human Genome Project, we have learned that the word “normal” no longer has meaning when it comes to a person’s genetic makeup. Genetic variations occur in great numbers in our genome (our total genetic makeup). We are all unique, not only in our personalities and appearance, but in our genotype as well.

Scientists continue to work on ways to better understand the structure of our genetic makeup, which could allow for important advances in the prevention and treatment of many diseases. There are promising new screening tests on the horizon, such as one for ovarian cancer or Alzheimer disease that researchers are trying to replicate in other disorders as well.

Gene therapy is an approach to treating potentially lethal and disabling diseases that are caused by single gene deficiencies. With specialised techniques, gene expression can be manipulated to correct the problem in the particular patient, although the correction will not be passed along to the offspring of that patient. That is, corrections are made at the DNA molecule level to compensate for the abnormal gene so that the detrimental symptoms of the disease are not expressed in the patient. It is still highly experimental. Clinical trials are being conducted to see if this can be used to develop treatments for other diseases, including cancer, heart disease, and AIDS.

Further advances in technology and molecular biology laboratory techniques have led to a recent invention - the “gene chip” or microarray – which allows many genes to be examined together instead of one at a time as is done now. Gene chips are still being developed and tested for clinical use.

Further advances in genetic testing will eventually replace older methods of predicting prognosis, helping to treat only those patients who will respond to therapy and by helping to guide further research into these therapies. Recent advances are also helping to increase our understanding of some complex cancers, such as multiple myeloma and lymphoma. Without a doubt, there will be more and more advances in genetic research that will impact the laboratory tests available to all patients for detection and treatment of a variety of diseases.



This article was originally written by Barbara Border, PhD. (Associate Professor and Program Director, Molecular Pathology. Texas Tech University Health Sciences Center, Lubbock, TX) for Lab Tests Online US. It has been slightly modified for the LTO Australasia site.


This page last modified on May 1, 2008.
 

In the newsUnderstanding your testsInside the Lab
About the siteSite mapSend us your commentsHome

If you don't know what a word or a medical term on this site means
use Stedman's online medical dictionary

We comply with the HONcode standard for trustworthy health
information:
verify here.

©2007-2008 all rights reserved
Email concerns to labtestsonlineau@aacb.asn.au

Terms of use Privacy